(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NP (NN Bax) (NN inhibitor-1)) (PRN (-LRB- -LRB-) (NP (NN BI-1)) (-RRB- -RRB-))))) (VP (VBZ induces) (NP (NN cell) (NN transformation)) (PP (IN in) (NP (NN NIH3T3) (NNS cells))))) (. .)))
(S1 (S (S (NP (NP (NP (NN BI-1)) (PRN (-LRB- -LRB-) (NP (NN Bax) (NN inhibitor-1)) (-RRB- -RRB-))) (, ,) (NP (NP (DT an) (JJ apoptosis-inhibiting) (NN gene)) (VP (VBG belonging) (PP (TO to) (NP (DT the) (NN Bcl-2) (NN protein) (NN family))))) (, ,)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (JJ mitochondrial) (NN apoptosis) (NN pathway)) (VP (TO to) (VP (VB suppress) (NP (JJ Bax-induced) (NN apoptosis)))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (NN BI-1))) (PP (IN in) (S (VP (VBG promoting) (NP (NN cell) (NP (NP (NN growth)) (CC and) (NP (NN tumorigenesis))))))))))) (, ,) (S (PP (IN in) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD overexpressed) (NP (NP (DT the) (NN BI-1) (NN gene)) (PP (IN in) (NP (NN NIH3T3) (NNS cells)))) (S (VP (VBG using) (NP (DT the) (JJ lentivirus-mediated) (NN gene) (NN expression) (NN system))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (ADJP (FW in) (FW vitro)) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN NIH3T3) (NNS cells)) (VP (VBG overexpressing) (NP (NN BI-1)))) (VP (VP (VBD displayed) (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN growth) (NN rate))) (CC and) (VP (VBD formed) (NP (ADJP (ADJP (JJR more)) (CC and) (ADJP (JJR larger))) (NNS colonies)) (PP (IN than) (NP (DT the) (JJ control) (NNS cells))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP$ our) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT the) (JJ lenti-BI-1-infected) (NNS cells)) (VP (VBD formed) (NP (JJ obvious) (NNS tumours)) (, ,) (SBAR (IN while) (S (NP (DT no) (NNS tumours)) (VP (VBD were) (VP (VBN formed) (PP (IN by) (NP (DT the) (JJ control) (NNS cells))) (SBAR (IN after) (S (ADVP (RB subcutaneously)) (VP (VBN injected) (PP (IN into) (NP (JJ nude) (NNS mice))))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (ADVP (RB strongly)) (VP (VBD suggested) (SBAR (IN that) (S (NP (DT the) (NN BI-1) (NN gene)) (VP (MD might) (VP (VB play) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (JJ neoplastic) (NN genesis)) (CC and) (NP (NN development)))))))))) (. .)))
